|
Volumn 74, Issue SUPPL.1, 2008, Pages 46-51
|
Postmarketing surveillance study of OxyContin® tablets for relieving moderate to severe cancer pain
|
Author keywords
Cancer pain; OxyContin tablets; Pain management; Postmarketing surveillance
|
Indexed keywords
OXYCODONE;
ABDOMINAL PAIN;
ADULT;
AGED;
CANCER PAIN;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONSTIPATION;
CONTROLLED STUDY;
DELIRIUM;
DISEASE SEVERITY;
DIZZINESS;
DRUG DOSE REDUCTION;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
DRUG WITHDRAWAL;
DYSURIA;
FACE PAIN;
FATIGUE;
FEMALE;
HEADACHE;
HUMAN;
ILLUSION;
LEG PAIN;
LETHARGY;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NAUSEA;
NECK PAIN;
PAIN ASSESSMENT;
POLYDIPSIA;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SHOULDER PAIN;
SKIN PRURITUS;
TABLET FORMULATION;
THORAX PAIN;
TREATMENT RESPONSE;
VISUAL ANALOG SCALE;
VOMITING;
ADULT;
AGED;
AGED, 80 AND OVER;
ANALGESICS, OPIOID;
DELAYED-ACTION PREPARATIONS;
DRUG UTILIZATION;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASMS;
OXYCODONE;
PAIN;
PAIN MEASUREMENT;
PALLIATIVE CARE;
PRODUCT SURVEILLANCE, POSTMARKETING;
PROSPECTIVE STUDIES;
TABLETS;
TREATMENT OUTCOME;
|
EID: 50849129568
PISSN: 00302414
EISSN: None
Source Type: Journal
DOI: 10.1159/000143218 Document Type: Conference Paper |
Times cited : (10)
|
References (5)
|